Members of the BioVentures team attended the BIO International Convention, held June 22–25 in San Diego, California, joining more than 20,000 biotechnology professionals from around the world. 

The annual convention brings together leaders from industry, academia, government, and investment organizations to explore new technologies, build partnerships, and discuss trends shaping the future of biotechnology. 

During the conference, the BioVentures team met with industry partners and technology transfer professionals to discuss commercialization opportunities for UAMS innovations while gaining insights into emerging developments across the life sciences sector. 

BIO is the world’s largest biotechnology convention and serves as a key forum for collaboration between researchers, entrepreneurs, investors, and business development leaders working to advance new healthcare technologies.